BSE Live
Apr 13, 16:01Prev. Close
57.09
Open Price
58.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Cash Flow of Aspira Pathlab & Diagnostics (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2.07 | -2.67 | -0.09 | 4.46 | 1.38 | |
| Net CashFlow From Operating Activities | 1.88 | 1.05 | -0.01 | 2.03 | 5.67 | |
| Net Cash Used In Investing Activities | 0.07 | 0.14 | 0.16 | -0.51 | -0.09 | |
| Net Cash Used From Financing Activities | -0.99 | -0.95 | -0.94 | -1.35 | -2.17 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.95 | 0.24 | -0.79 | 0.17 | 3.41 | |
| Cash And Cash Equivalents Begin of Year | 0.80 | 0.57 | 1.35 | 1.19 | -2.22 | |
| Cash And Cash Equivalents End Of Year | 1.75 | 0.80 | 0.57 | 1.35 | 1.19 |
25.02.2026
Aspira Pathlab Standalone December 2025 Net Sales at Rs 5.12 crore, down 5.34% Y-o-Y
13.08.2025
Aspira Pathlab Consolidated June 2025 Net Sales at Rs 5.25 crore, up 13.17% Y-o-Y
19.05.2025
Aspira Pathlab Standalone March 2025 Net Sales at Rs 5.78 crore, up 51.31% Y-o-Y
10.02.2025
Aspira Pathlab Standalone December 2024 Net Sales at Rs 5.41 crore, up 56.21% Y-o-Y